Edition:
United States

Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

3.47USD
17 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.47
Open
$3.46
Day's High
$3.46
Day's Low
$3.46
Volume
20
Avg. Vol
8,260
52-wk High
$8.91
52-wk Low
$2.97

Chart for

About

Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed’s flagship product, an orally ingestible insulin capsule in phase II clinical trials, is focused on the treatment of diabetes. The Company is developing orally ingestible... (more)

Overall

Beta: 0.52
Market Cap(Mil.): $68.58
Shares Outstanding(Mil.): 17.36
Dividend: --
Yield (%): --

Financials

  ORMP.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.88 -- --
ROI: -39.19 0.60 13.80
ROE: -68.54 -2.18 15.29

Earnings vs. Estimates